Thus, we conclude that promoter hypermethylation is a key mechanism suppressing ESRP1 in RCC, and 5-Aza-CdR reactivates ESRP1 primarily through promoter demethylation. The gene discussed is ESRP1; the disease is renal cell carcinoma.